USNA icon

Usana Health Sciences

30.26 USD
-1.18
3.75%
At close Jul 29, 4:00 PM EDT
After hours
30.86
+0.60
1.98%
1 day
-3.75%
5 days
-18.22%
1 month
-0.88%
3 months
8.50%
6 months
-12.85%
Year to date
-16.85%
1 year
-30.28%
5 years
-62.84%
10 years
-51.65%
 

About: Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

Employees: 1,700

0
Funds holding %
of 7,323 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

45% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 22

28% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 46

12% more call options, than puts

Call options by funds: $232K | Put options by funds: $207K

6% more funds holding

Funds holding: 152 [Q4 2024] → 161 (+9) [Q1 2025]

0.2% more ownership

Funds ownership: 56.57% [Q4 2024] → 56.77% (+0.2%) [Q1 2025]

25% less capital invested

Capital invested by funds: $387M [Q4 2024] → $290M (-$97.4M) [Q1 2025]

Research analyst outlook

We haven’t received any recent analyst ratings for USNA.

Financial journalist opinion

Based on 10 articles about USNA published over the past 30 days

Positive
Zacks Investment Research
5 days ago
USANA Health (USNA) Upgraded to Buy: Here's Why
USANA Health (USNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
USANA Health (USNA) Upgraded to Buy: Here's Why
Positive
Zacks Investment Research
5 days ago
USNA or ZTS: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Drugs stocks have likely encountered both USANA Health Sciences (USNA) and Zoetis (ZTS). But which of these two stocks presents investors with the better value opportunity right now?
USNA or ZTS: Which Is the Better Value Stock Right Now?
Positive
Seeking Alpha
5 days ago
USANA Health Sciences: Hiya's Potential Is Showing
USANA Health Sciences is resurfacing as an idea after a strong Q2 report. The direct selling business has continued to struggle with a decline in sales and active customers. A segment turnaround remains uncertain. The previous Hiya acquisition's potential is clearly showing. Operational expansion underlines massive long-term potential for USANA.
USANA Health Sciences: Hiya's Potential Is Showing
Neutral
Seeking Alpha
6 days ago
USANA Health Sciences, Inc. (USNA) Q2 2025 Earnings Call Transcript
USANA Health Sciences, Inc. (NYSE:USNA ) Q2 2025 Earnings Conference Call July 23, 2025 11:00 AM ET Company Participants Andrew Masuda - Director of Investor Relations Brent L. Neidig - Chief Commercial Officer G.
USANA Health Sciences, Inc. (USNA) Q2 2025 Earnings Call Transcript
Positive
Zacks Investment Research
1 week ago
USANA Health Sciences (USNA) Q2 Earnings and Revenues Top Estimates
USANA Health Sciences (USNA) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.54 per share. This compares to earnings of $0.54 per share a year ago.
USANA Health Sciences (USNA) Q2 Earnings and Revenues Top Estimates
Neutral
Business Wire
1 week ago
USANA Health Sciences Reports Second Quarter 2025 Results and Reiterates Full-Year Outlook
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended June 28, 2025. Key Financial Results Second Quarter 2025 vs. Second Quarter 2024 Net sales of $236 million versus $213 million, representing 11% year-over-year growth. Net earnings of $9.7 million versus $10.4 million. Diluted EPS of $0.52 as compared with $0.54. Adjusted diluted EPS(1) of $0.74 as compared with $0.54. Adjusted EBITDA(2) of $30 million.
USANA Health Sciences Reports Second Quarter 2025 Results and Reiterates Full-Year Outlook
Positive
Seeking Alpha
3 weeks ago
USANA Health Sciences: Premium Formulation, Discounted Valuation
USANA Health Sciences' pivot from MLM to omnichannel, highlighted by the Hiya Health acquisition, marks a strategic inflection point for renewed growth and relevance. The company's scientific credibility, strong balance sheet, and global reach position it well, despite recent revenue declines and heavy China exposure. Valuation is attractive at 12× forward earnings and 5× EBITDA, with catalysts including Hiya's growth, margin expansion, and potential buybacks.
USANA Health Sciences: Premium Formulation, Discounted Valuation
Neutral
Business Wire
3 weeks ago
USANA Schedules Second Quarter 2025 Earnings Release and Conference Call
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that second quarter 2025 results will be released after the close of market on Tuesday, July 22, 2025. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and instit.
USANA Schedules Second Quarter 2025 Earnings Release and Conference Call
Neutral
PRNewsWire
3 weeks ago
USANA Executive Chairman Kevin Guest Invites All to Discover Freedom in July
SALT LAKE CITY , July 2, 2025 /PRNewswire/ -- With freedom as a universal desire being celebrated this month, Kevin Guest, Executive Chairman of USANA Health Sciences (NYSE: USNA), is inspiring individuals and families to celebrate freedom on a personal level for self-care. Research reveals countless global celebrations honoring freedom—from America's Independence Day on July 4 to the unifying spirit of Canada Day on July 1 and numerous others around the world.
USANA Executive Chairman Kevin Guest Invites All to Discover Freedom in July
Neutral
PRNewsWire
4 weeks ago
USANA Announces the Elevation of Its Opportunity
Enhanced incentives, a renewed brand story, and stronger sales system are aimed at driving early success and sustainable growth for USANA Brand Partners SALT LAKE CITY , July 1, 2025 /PRNewswire/ -- USANA, a global leader in cellular nutrition, announced an elevated opportunity to its global Brand Partners this week, including an updated brand story and enhanced compensation plan. The updated incentives fully launch in October and give USANA Brand Partners improved tools for attracting and retaining new customers and team members.
USANA Announces the Elevation of Its Opportunity
Charts implemented using Lightweight Charts™